EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Nurse practitioner‐delivered cognitive–behavioral treatment as a novel implementation route for irritable bowel syndrome: A proof of concept

Helen Burton Murray iD, Imani Weeks, Andrea Thurler, Samantha Calabrese, Mary Kate Lapinel, Elizabeth N Madva iD, Kyle Staller iD, Laurie Keefer, Braden Kuo

Neurogastroenterology & Motility · 2023

DOI: 10.1111/nmo.14526 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Neurogastroenterology & Motility, 2023. Verfasst von Helen Burton Murray und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Harvard Medical School, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Exposure‐based cognitive–behavioral therapy (exposure‐CBT) is efficacious for irritable bowel syndrome (IBS). However, few patients receive exposure‐CBT due to a lack of behavioral health providers trained in brain–gut behavior therapies. Nurse practitioners (NPs) could fill a critical need for scalable delivery methods. In a pragmatic investigation of a 5‐session NP‐delivered exposure‐CBT for adults with Rome IV‐defined IBS, we evaluated treatment feasibility and acceptability and explored changes clinical outcomes.

Methods

Exposure‐CBT was delivered as part of routine care involving four sessions every other week and a 2‐month booster session. Patients could electively participate in an observational study including pre‐, mid‐, and post‐treatment surveys and a post‐treatment qualitative interview. Independently coded ratings of NP treatment protocol adherence and competence ratings were completed from audio recordings, rated on a 1 (not at all) to 5 (completely) scale.

Results

Twenty‐five patients consented (ages 22‐67 years; 76% female; 48% IBS‐diarrhea predominant). There was high feasibility—adherence average = 4.1, NP competence average = 4.8, 72% treatment completion, 93% satisfaction scores ≥3. Treatment satisfaction was high (rated as 4/4 “very satisfied” by n = 9 and as 3/4 “mostly satisfied” by n = 5). There were improvements in clinical outcomes across treatment with large effects for IBS‐symptom severity (−53%; Hedge's g = 1.0; 95% confidence interval [CI] = 0.5, 1.5) and IBS quality of life (+31%; Hedge's g = 0.8; 95% CI = 0.4, 1.2).

Conclusions

NP‐delivered exposure‐CBT for IBS was initially feasible and acceptable with promising clinical improvements. Findings will inform a future NIH Stage 1B/ORBIT Phase IIB pilot randomized control trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeCognitive Behavioral TherapyAdultHumansFemaleYoung AdultMiddle AgedAgedMaleQuality of LifeTreatment OutcomeCognition

Stichwörter der Autor:innen

cognitive-behavioral therapydisorders of gut-brain interactionfunctional gastrointestinal disordersirritable bowel syndromenurse practitionersnurses

Autor:innen und Institutionen

  • Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
  • Center for Neurointestinal Health, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Helen Burton Murray, Elizabeth N Madva, Kyle Staller

Förderung

  • NIDDK NIH HHS
  • Harvard Medical School
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Burton Murray, H., Weeks, I., Thurler, A., Calabrese, S., Kate Lapinel, M., Madva, E. N., Staller, K., Keefer, L., & Kuo, B. (2023). Nurse practitioner‐delivered cognitive–behavioral treatment as a novel implementation route for irritable bowel syndrome: A proof of concept. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14526

Vancouver

Burton Murray H, Weeks I, Thurler A, Calabrese S, Kate Lapinel M, Madva EN, et al. Nurse practitioner‐delivered cognitive–behavioral treatment as a novel implementation route for irritable bowel syndrome: A proof of concept. Neurogastroenterology & Motility. 2023. doi:10.1111/nmo.14526

BibTeX
@article{BurtonMurray2023,
  author = {Burton Murray, Helen and Weeks, Imani and Thurler, Andrea and Calabrese, Samantha and Kate Lapinel, Mary and Madva, Elizabeth N and Staller, Kyle and Keefer, Laurie and Kuo, Braden},
  title = {Nurse practitioner‐delivered cognitive–behavioral treatment as a novel implementation route for irritable bowel syndrome: A proof of concept},
  journal = {Neurogastroenterology & Motility},
  year = {2023},
  doi = {10.1111/nmo.14526}
}
Kostenlos starten →